Total submissions: 7
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Clin |
RCV000519096 | SCV000616492 | likely benign | RASopathy | 2017-04-18 | reviewed by expert panel | curation | The filtering allele frequency of the c.38A>C (p.Glu13Ala) variant in the SHOC2 gene is 0.0484% (10/11206) of Latino chromosomes by the Exome Aggregation Consortium, which is a high enough frequency to be classified as likely benign based on thresholds defined by the ClinGen RASopathy Expert Panel (BS1; PMID:29493581) |
Gene |
RCV000159108 | SCV000209052 | benign | not provided | 2016-06-06 | criteria provided, single submitter | clinical testing | This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. |
Eurofins Ntd Llc |
RCV000159108 | SCV000859601 | uncertain significance | not provided | 2018-02-06 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV000519096 | SCV001129609 | likely benign | RASopathy | 2024-01-27 | criteria provided, single submitter | clinical testing | |
ARUP Laboratories, |
RCV001286466 | SCV001473041 | likely benign | Noonan syndrome-like disorder with loose anagen hair 1 | 2020-07-06 | criteria provided, single submitter | clinical testing | |
Fulgent Genetics, |
RCV001286466 | SCV002799128 | likely benign | Noonan syndrome-like disorder with loose anagen hair 1 | 2021-09-08 | criteria provided, single submitter | clinical testing | |
Prevention |
RCV003917545 | SCV004730189 | likely benign | SHOC2-related disorder | 2020-08-04 | no assertion criteria provided | clinical testing | This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). |